Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Cohen

Showing results (351-360 of 403) with videos related to

Pageof 41
Sort By:
Circulation|November 1, 2017
Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic AtherosclerosisIlaria Cavallari, David A Morrow, Mark A Creager, et al.
Journal of General Internal Medicine|January 16, 2008
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trialKenneth W Mahaffey, Qinghong Yang, Karen S Pieper, et al.
JAMA|November 24, 2005
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trialKenneth W Mahaffey, Marc Cohen, Jyotsna Garg, et al.
The American Journal of Medicine|August 21, 2016
Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial)Rohan Shah, Robert M Clare, Karen Chiswell, et al.
Circulation|May 22, 2002
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET TrialGregg W Stone, David J Moliterno, Michel Bertrand, et al.
American Heart Journal|March 21, 2016
Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trialLouis P Kohl, Jeffrey D Leimberger, Karen Chiswell, et al.
Circulation. Cardiovascular Interventions|February 2, 2019
Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary InterventionMathieu Kerneis, Megan K Yee, Roxana Mehran, et al.
American Journal of Surgery|May 25, 2006
The use of virtual patients to teach medical students history taking and communication skillsAmy Stevens, Jonathan Hernandez, Kyle Johnsen, et al.
Circulation. Cardiovascular Interventions|November 12, 2019
Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI TrialMathieu Kerneis, Megan K Yee, Roxana Mehran, et al.
Circulation. Cardiovascular Quality and Outcomes|February 10, 2011
The impact of postrandomization crossover of therapy in acute coronary syndromes careKenneth W Mahaffey, Karen S Pieper, Yuliya Lokhnygina, et al.
Pageof 41

Showing results (351-360 of 403) with videos related to

Sort By:
Pageof 41
Circulation|November 1, 2017
Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic AtherosclerosisIlaria Cavallari, David A Morrow, Mark A Creager, et al.
Journal of General Internal Medicine|January 16, 2008
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trialKenneth W Mahaffey, Qinghong Yang, Karen S Pieper, et al.
JAMA|November 24, 2005
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trialKenneth W Mahaffey, Marc Cohen, Jyotsna Garg, et al.
The American Journal of Medicine|August 21, 2016
Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial)Rohan Shah, Robert M Clare, Karen Chiswell, et al.
Circulation|May 22, 2002
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET TrialGregg W Stone, David J Moliterno, Michel Bertrand, et al.
American Heart Journal|March 21, 2016
Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trialLouis P Kohl, Jeffrey D Leimberger, Karen Chiswell, et al.
Circulation. Cardiovascular Interventions|February 2, 2019
Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary InterventionMathieu Kerneis, Megan K Yee, Roxana Mehran, et al.
American Journal of Surgery|May 25, 2006
The use of virtual patients to teach medical students history taking and communication skillsAmy Stevens, Jonathan Hernandez, Kyle Johnsen, et al.
Circulation. Cardiovascular Interventions|November 12, 2019
Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI TrialMathieu Kerneis, Megan K Yee, Roxana Mehran, et al.
Circulation. Cardiovascular Quality and Outcomes|February 10, 2011
The impact of postrandomization crossover of therapy in acute coronary syndromes careKenneth W Mahaffey, Karen S Pieper, Yuliya Lokhnygina, et al.
Pageof 41